InfuSystem Q3 2025 revenue $36.5M (+3% YoY), net income $2.3M (+25%), reaffirms 2025 guidance

InfuSystem Holdings, Inc

2025-Q3 EPS reported $0.22 vs consensus $0.08 ▲ beat (+169.6%)

Net revenues $36.5M (record), up 3% vs. $35.3M a year ago; Patient Services up 8%, Device Solutions down 3%.
Net income $2.3M ($0.11 diluted EPS) vs. $1.8M ($0.08) prior year, a 25% increase.
Adjusted EBITDA $8.3M (+6%), margin 22.8% (up 0.5pp); YTD operating cash flow $17.3M (+38%).
Wound care revenue surged 115% YoY ($1.0M); new contract with large hospital system and payer extension secured.
Reaffirms full-year 2025 guidance: net revenue growth 6-8%, Adjusted EBITDA margin 20%+.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.